Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 521 items for :

  • late effects x
Clear All
Izabelle Lövgren Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Search for other papers by Izabelle Lövgren in
Google Scholar
PubMed Close
,
Azadeh Abravan Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Azadeh Abravan in
Google Scholar
PubMed Close
,
Abigail Bryce-Atkinson Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Search for other papers by Abigail Bryce-Atkinson in
Google Scholar
PubMed Close
, and
Marcel van Herk Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Marcel van Herk in
Google Scholar
PubMed Close

efficacy and detrimental side effects, such as secondary neoplasms and endocrine deficiencies, is still needed. As the survival rate has also increased, patients are now living long enough to see these late effects. Common oncological treatments include

Article Type:
Review Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-22-0298
Volume/Issue:
Volume 11: Issue 12
Open access
Judith Gebauer Department of Internal Medicine I, University Hospital Schleswig-Holstein, Luebeck, Germany

Search for other papers by Judith Gebauer in
Google Scholar
PubMed Close
and
Claire E Higham Department of Endocrinology, Christie Hospital NHS Foundation Trust, University of Manchester, and Manchester Academic Health Science Centre, Manchester, UK

Search for other papers by Claire E Higham in
Google Scholar
PubMed Close

represent a comparably small group of patients in this large cohort that have been studied for decades due to their excellent long-term survival rates and the long life span ahead of them after the end of treatment. Much knowledge about late effects is

Article Type:
Editorial
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0261
Volume/Issue:
Volume 11: Issue 9
Open access
David S McLaren Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospital NHS Trust, Leeds, UK

Search for other papers by David S McLaren in
Google Scholar
PubMed Close
,
Aarani Devi Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospital NHS Trust, Leeds, UK

Search for other papers by Aarani Devi in
Google Scholar
PubMed Close
,
Nikolaos Kyriakakis Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospital NHS Trust, Leeds, UK

Search for other papers by Nikolaos Kyriakakis in
Google Scholar
PubMed Close
,
Michelle Kwok-Williams Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospital NHS Trust, Leeds, UK

Search for other papers by Michelle Kwok-Williams in
Google Scholar
PubMed Close
, and
Robert D Murray Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospital NHS Trust, Leeds, UK
Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Robert D Murray in
Google Scholar
PubMed Close

disease; however, an increase in cardiovascular mortality ( 5 ) and risk of early- and late-occurring stroke ( 6 , 7 ) are also observed. As a consequence, survivors are more likely to be hospitalised compared with the general population. Effects of

Article Type:
Review Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-22-0490
Volume/Issue:
Volume 12: Issue 9
Open access
J Gebauer Department of Internal Medicine I, University Hospital of Schleswig-Holstein, Campus Luebeck and Institute for Endocrinology and Diabetes, University of Luebeck, Luebeck, Germany

Search for other papers by J Gebauer in
Google Scholar
PubMed Close
,
R Skinner Department of Paediatric and Adolescent Haematology and Oncology and Children’s BMT Unit, Great North Children’s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK

Search for other papers by R Skinner in
Google Scholar
PubMed Close
,
R Haupt DOPO Clinic, Department of Hematology/Oncolgy, IRCCS Istituto Giannina Gaslini, Genova, Italy

Search for other papers by R Haupt in
Google Scholar
PubMed Close
,
L Kremer Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Amsterdam UMC, Emma’s Children’s Hospital, Amsterdam, The Netherlands

Search for other papers by L Kremer in
Google Scholar
PubMed Close
,
H van der Pal Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Search for other papers by H van der Pal in
Google Scholar
PubMed Close
,
G Michel Department of Health Sciences and Medicine, University of Lucerne, Luzern, Switzerland

Search for other papers by G Michel in
Google Scholar
PubMed Close
,
G T Armstrong Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA

Search for other papers by G T Armstrong in
Google Scholar
PubMed Close
,
M M Hudson Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA

Search for other papers by M M Hudson in
Google Scholar
PubMed Close
,
L Hjorth Department of Clinical Sciences Lund, Paediatrics, Lund University, Skane University Hospital, Lund, Sweden

Search for other papers by L Hjorth in
Google Scholar
PubMed Close
,
H Lehnert Paris Lodron University of Salzburg, Salzburg, Austria

Search for other papers by H Lehnert in
Google Scholar
PubMed Close
, and
T Langer Pediatric Hematology and Oncology, University Hospital of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany

Search for other papers by T Langer in
Google Scholar
PubMed Close

-term survivors suffer from treatment-related late effects, which may occur years to decades after the completion of therapy ( 2 ). Increasing knowledge and recognition of these sequelae resulted in, whenever possible, a reduction or even elimination of

Article Type:
Review Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0083
Volume/Issue:
Volume 11: Issue 9
Open access
Paraskevi Kazakou Diabetes Centre, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Paraskevi Kazakou in
Google Scholar
PubMed Close
,
Stavroula A Paschou Endocrine Unit, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Stavroula A Paschou in
Google Scholar
PubMed Close
,
Theodora Psaltopoulou Unit of Hematology and Oncology, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Theodora Psaltopoulou in
Google Scholar
PubMed Close
,
Maria Gavriatopoulou Unit of Hematology and Oncology, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Maria Gavriatopoulou in
Google Scholar
PubMed Close
,
Eleni Korompoki Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Eleni Korompoki in
Google Scholar
PubMed Close
,
Katerina Stefanaki Endocrine Unit, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Katerina Stefanaki in
Google Scholar
PubMed Close
,
Fotini Kanouta Department of Endocrinology, Alexandra Hospital, Athens, Greece

Search for other papers by Fotini Kanouta in
Google Scholar
PubMed Close
,
Georgia N Kassi Department of Endocrinology, Alexandra Hospital, Athens, Greece

Search for other papers by Georgia N Kassi in
Google Scholar
PubMed Close
,
Meletios-Athanasios Dimopoulos Unit of Hematology and Oncology, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Meletios-Athanasios Dimopoulos in
Google Scholar
PubMed Close
, and
Asimina Mitrakou Diabetes Centre, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Asimina Mitrakou in
Google Scholar
PubMed Close

, and mortality of COVID-19 ( 22 , 23 , 24 , 25 , 26 ). On top of the above, early and late effects of COVID-19 on glucose metabolism are of great interest. Importantly, COVID-19 may worsen glucose homeostasis. COVID-19 infection is characterized

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-21-0184
Volume/Issue:
Volume 10: Issue 9
Open access
Mark R Postma Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by Mark R Postma in
Google Scholar
PubMed Close
,
Pia Burman Department of Endocrinology, Skane University Hospital Malmö, University of Lund, Lund, Sweden

Search for other papers by Pia Burman in
Google Scholar
PubMed Close
, and
André P van Beek Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by André P van Beek in
Google Scholar
PubMed Close

compared to late initiation. Methods Study population The KIMS database (Pfizer International Metabolic Database) was used to study the effects of hypopituitarism on obesity. KIMS, initiated in 1994, is a pharmaco-epidemiological multicentre

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0098
Volume/Issue:
Volume 9: Issue 7
Open access
B Shahida Department of Clinical Sciences, Genomics, Diabetes and Endocrinology, Lund University, Malmö, Sweden
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden

Search for other papers by B Shahida in
Google Scholar
PubMed Close
,
P Sahlstrand Johnson Department of Oto-Rhino-Laryngology, Skåne University Hospital, Malmö, Sweden
Department of Clinical Sciences, Lund University, Malmö, Sweden

Search for other papers by P Sahlstrand Johnson in
Google Scholar
PubMed Close
,
R Jain Department of Clinical Sciences, Genomics, Diabetes and Endocrinology, Lund University, Malmö, Sweden

Search for other papers by R Jain in
Google Scholar
PubMed Close
,
H Brorson Department of Clinical Sciences, Lund University, Malmö, Sweden
Department of Plastic Surgery, Skåne University Hospital, Malmö, Sweden

Search for other papers by H Brorson in
Google Scholar
PubMed Close
,
P Åsman Department of Clinical Sciences Malmö, Ophthalmology, Lund University, Malmö, Sweden
Department of Ophthalmology, Skåne University Hospital, Malmö, Sweden

Search for other papers by P Åsman in
Google Scholar
PubMed Close
,
M Lantz Department of Clinical Sciences, Genomics, Diabetes and Endocrinology, Lund University, Malmö, Sweden
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden

Search for other papers by M Lantz in
Google Scholar
PubMed Close
, and
T Planck Department of Clinical Sciences, Genomics, Diabetes and Endocrinology, Lund University, Malmö, Sweden
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden

Search for other papers by T Planck in
Google Scholar
PubMed Close

( Fig. 7 ). Figure 7 Effects of simvastatin on adipogenesis in human primary orbital fibroblasts. Orbital fibroblasts were treated with simvastatin and differentiation cocktail (DC) for 1–12 days. Gene expression was quantified with RT-PCR of late

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0319
Volume/Issue:
Volume 8: Issue 9
Open access
Esben S Lauritzen The Medical Research Laboratories, Institute of Clinical Research, Aarhus University, Aarhus C, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark

Search for other papers by Esben S Lauritzen in
Google Scholar
PubMed Close
,
Nikolaj Rittig The Medical Research Laboratories, Institute of Clinical Research, Aarhus University, Aarhus C, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark

Search for other papers by Nikolaj Rittig in
Google Scholar
PubMed Close
,
Ermina Bach The Medical Research Laboratories, Institute of Clinical Research, Aarhus University, Aarhus C, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark

Search for other papers by Ermina Bach in
Google Scholar
PubMed Close
,
Niels Møller The Medical Research Laboratories, Institute of Clinical Research, Aarhus University, Aarhus C, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark

Search for other papers by Niels Møller in
Google Scholar
PubMed Close
, and
Mette Bjerre The Medical Research Laboratories, Institute of Clinical Research, Aarhus University, Aarhus C, Denmark

Search for other papers by Mette Bjerre in
Google Scholar
PubMed Close

exposure, we believe that the late inflammatory FGF21 response in both mice and human is caused by the secondary metabolic effects to the APR, but further studies are required to confirm this hypothesis. There are certain limitations to our study. First

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-16-0103
Volume/Issue:
Volume 6: Issue 1
Open access
Ferdinand Roelfsema Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Ferdinand Roelfsema in
Google Scholar
PubMed Close
,
Diana van Heemst Department of Internal Medicine, Section Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Diana van Heemst in
Google Scholar
PubMed Close
,
Ali Iranmanesh Endocrine Section, Medical Service, Salem Veterans Affairs Medical Center, Salem, Virginia, USA

Search for other papers by Ali Iranmanesh in
Google Scholar
PubMed Close
,
Paul Takahashi Primary Care Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Paul Takahashi in
Google Scholar
PubMed Close
,
Rebecca Yang Endocrine Research Unit, Mayo Medical and Graduate Schools, Clinical Translational Research Center, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Rebecca Yang in
Google Scholar
PubMed Close
, and
Johannes D Veldhuis Endocrine Research Unit, Mayo Medical and Graduate Schools, Clinical Translational Research Center, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Johannes D Veldhuis in
Google Scholar
PubMed Close

men than women during daytime only. As shown in 3 different age cohorts in Fig. 1 , older individuals had higher cortisol in the late evening and early night ( Table 3 ). Regression analyses delineated positive correlations with age between clock

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0160
Volume/Issue:
Volume 6: Issue 7
Open access
Marcus Imamovic Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Search for other papers by Marcus Imamovic in
Google Scholar
PubMed Close
,
Nils Bäcklund Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Search for other papers by Nils Bäcklund in
Google Scholar
PubMed Close
,
Staffan Lundstedt Department of Medical Biosciences, Umeå University, Umeå, Sweden

Search for other papers by Staffan Lundstedt in
Google Scholar
PubMed Close
,
Göran Brattsand Department of Medical Biosciences, Umeå University, Umeå, Sweden

Search for other papers by Göran Brattsand in
Google Scholar
PubMed Close
,
Elisabeth Aardal Department of Clinical Chemistry and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden

Search for other papers by Elisabeth Aardal in
Google Scholar
PubMed Close
,
Tommy Olsson Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Search for other papers by Tommy Olsson in
Google Scholar
PubMed Close
, and
Per Dahlqvist Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Search for other papers by Per Dahlqvist in
Google Scholar
PubMed Close

) ( 27 ), CV A is the interassay coefficient of variation for the analytical method (7% for both cortisol and cortisone), and CV is each individual's CV based on the baseline late-night salivary samples. Effects of liquorice on blood pressure and

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-22-0324
Volume/Issue:
Volume 12: Issue 1
Open access